Company intelligence / Profile preview
Alloksys Life Sciences
- Ownership
- Private
- Development stage
- Other
Overview
Alloksys Life Sciences has developed RESCAP®, an alkaline phosphatase-based therapeutic aimed at reducing inflammation-triggered complications in critical care settings. In a Phase IIb trial with patients undergoing cardiothoracic surgery, the primary endpoint of reduced acute kidney injury was not met for the total cohort but was achieved in a subgroup with normal renal function. A continuation into Phase III trials with longer administration times aims to confirm broader benefit. The company also has ongoing or completed studies in burns, rheumatoid arthritis, kidney transplantation, and COVID-related indications[10].
- Therapeutic areas
- CardiovascularRheumatologyNephrologyImmunologyDermatologyOther
- Modalities
- Enzyme therapy (alkaline phosphatase-based)Recombinant protein therapeutics
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Alloksys Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alloksys Life Sciences.